{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:33:14Z","timestamp":1787931194043,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117891","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:57:08Z","timestamp":1750359428000},"page":"117891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation"],"prefix":"10.1016","volume":"296","author":[{"given":"Islam M.","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Ali","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"Abu-Baih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mohamed badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Hayallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GamalEl-Din A.","family":"Abuo-Rahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117891_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117891_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106638","article-title":"New benzothienopyran and benzothienopyranopyrimidine derivatives as topoisomerase I inhibitors: design, synthesis, anticancer screening, apoptosis induction and molecular modeling studies","volume":"137","author":"Khalil","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117891_bib4","article-title":"Design, synthesis and antiproliferative evaluation of new acridine-thiosemicarbazone derivatives as topoisomerase II\u03b1 inhibitors","volume":"7","author":"Sousa","year":"2024","journal-title":"Results Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117891_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.2910590506","article-title":"Topoisomerase I and II activity in human breast, cervix, lung and colon cancer","volume":"59","author":"McLeod","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117891_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114304","article-title":"Topoisomerase I inhibitors: challenges, progress and the road ahead","volume":"236","author":"Talukdar","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-1033.1996.0195h.x","article-title":"Sequence\u2010selective intercalation of antitumour bis\u2010naphthalimides into DNA: evidence for an approach via the major groove","volume":"240","author":"Bailly","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(03)00058-5","article-title":"Catalytic topoisomerase II inhibitors in cancer therapy","volume":"99","author":"Larsen","year":"2003","journal-title":"Pharmacol. Therapeut."},{"issue":"37","key":"10.1016\/j.ejmech.2025.117891_bib9","doi-asserted-by":"crossref","first-page":"21429","DOI":"10.1074\/jbc.270.37.21429","article-title":"Topoisomerase poisons: harnessing the dark side of enzyme mechanism","volume":"270","author":"Froelich-Ammon","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117891_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104629","article-title":"Novel Mannich bases of ciprofloxacin with improved physicochemical properties, antibacterial, anticancer activities and caspase-3 mediated apoptosis","volume":"107","author":"Abdel-Rahman","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117891_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117891_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jcb.240510208","article-title":"4\u2010Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells","volume":"51","author":"Lawrence","year":"1993","journal-title":"J. Cell. Biochem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117891_bib14","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.3390\/molecules27227993","article-title":"Dual topoisomerase I\/II inhibition-induced apoptosis and necro-apoptosis in cancer cells by a novel ciprofloxacin derivative via RIPK1\/RIPK3\/MLKL activation","volume":"27","author":"Alaaeldin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117891_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104422","article-title":"Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I\/II inhibitory activities and caspases-mediated apoptosis","volume":"106","author":"Mohammed","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14756366.2022.2136172","article-title":"Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme","volume":"38","author":"Swedan","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867304666220309194437","article-title":"Anticancer and cytotoxic properties of mannich bases","volume":"4","author":"Dimmock","year":"1997","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117891_bib18","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3892\/ijo.2014.2611","article-title":"Ciprofloxacin containing mannich base and its copper complex induce antitumor activity via different mechanism of action","volume":"45","author":"Fu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117891_bib19","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.3390\/molecules17066179","article-title":"Synthesis of chalcones with anticancer activities","volume":"17","author":"Syam","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14756366.2021.1976772","article-title":"A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors","volume":"37","author":"Liu","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.phrs.2008.02.005","article-title":"Antiangiogenic effects of flavonoids and chalcones","volume":"57","author":"Mojzis","year":"2008","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms26020833","article-title":"Synthesis and anticancer evaluation of O-Alkylated (E)-Chalcone derivatives: a focus on estrogen receptor inhibition","volume":"26","author":"Al-Ghamdi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117891_bib23","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1016\/j.bmcl.2013.03.106","article-title":"Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents","volume":"23","author":"Kim","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bmcl.2010.11.037","article-title":"Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy-and thiiranylmethoxy-chalcone derivatives","volume":"21","author":"Na","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117891_bib25","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/slct.201702913","article-title":"N\u2010substituted 1, 2, 3\u2010triazolyl\u2010appended indole\u2010chalcone hybrids as potential DNA intercalators endowed with antioxidant and anticancer properties","volume":"3","author":"Aneja","year":"2018","journal-title":"ChemistrySelect"},{"issue":"52","key":"10.1016\/j.ejmech.2025.117891_bib26","doi-asserted-by":"crossref","first-page":"31139","DOI":"10.1039\/D0RA05594H","article-title":"Molecular targets and anticancer activity of quinoline\u2013chalcone hybrids: literature review","volume":"10","author":"Mohamed","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117891_bib27","series-title":"Mannich Bases of Chalcones and Cyclohexanones as Candidate Cytotoxic Agents","author":"Kandepu","year":"1999"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117891_bib28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/jm970432t","article-title":"Cytotoxic activities of mannich bases of chalcones and related compounds","volume":"41","author":"Dimmock","year":"1998","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117891_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10600-021-03380-4","article-title":"Synthesis and antiproliferative activity of prenylated chalcone mannich base derivatives","volume":"57","author":"Su","year":"2021","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.ejmech.2025.117891_bib30","series-title":"The Complete Mechanism of Chalcone Formation","author":"Chang","year":"2015"},{"key":"10.1016\/j.ejmech.2025.117891_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108163","article-title":"New series of fluoroquinolone derivatives as potential anticancer agents: design, synthesis, in vitro biological evaluation, and Topoisomerase II inhibition","volume":"156","author":"Adly","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117891_bib32","unstructured":"INVALID CITATION !!!."},{"issue":"19","key":"10.1016\/j.ejmech.2025.117891_bib33","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1016\/j.bmc.2006.06.020","article-title":"Synthesis and in vitro antitumor evaluation of some indeno [1, 2-c] pyrazol (in) es substituted with sulfonamide, sulfonylurea (-thiourea) pharmacophores, and some derived thiazole ring systems","volume":"14","author":"Rostom","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117891_bib34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0026-895X(25)09546-X","article-title":"Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells","volume":"50","author":"Lawrence","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117891_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568026033452537","article-title":"Fluoroquinolones: action and resistance","volume":"3","author":"Drlica","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117891_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"27","key":"10.1016\/j.ejmech.2025.117891_bib37","doi-asserted-by":"crossref","first-page":"12271","DOI":"10.1039\/D1NJ02163J","article-title":"Synthesis and evaluation of the antiproliferative activity of new heterylmethylidene derivatives of imidazothiazolotriazinones","volume":"45","author":"Izmest'ev","year":"2021","journal-title":"New J. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117891_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1535-7163.MCT-10-0106","article-title":"Analysis of food and drug Administration\u2013approved anticancer agents in the NCI60 panel of human tumor cell lines","volume":"9","author":"Holbeck","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib39","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3390\/ijms22041961","article-title":"Ym155 induces oxidative stress-mediated DNA damage and cell cycle arrest, and causes programmed cell death in anaplastic thyroid cancer cells","volume":"22","author":"Xu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117891_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4014\/jmb.2205.05012","article-title":"Induction of cell cycle arrest, apoptosis, and reducing the expression of MCM proteins in human lung carcinoma A549 cells by cedrol, isolated from Juniperus chinensis","volume":"32","author":"Yun","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/mjmr.2021.241645","article-title":"Pathways of triple negative breast cancer","volume":"32","author":"Nazmy","year":"2021","journal-title":"Minia J. Med. Res."},{"key":"10.1016\/j.ejmech.2025.117891_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104884","article-title":"The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: in silico and in vitro study","volume":"66","author":"Beberok","year":"2020","journal-title":"Toxicol. Vitro"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib43","first-page":"233","article-title":"Ciprofloxacin inhibits proliferation and promotes generation of aneuploidy in Jurkat cells","volume":"61","author":"Koziel","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117891_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jinorgbio.2016.02.018","article-title":"A novel dual-functioning ruthenium (II)\u2013arene complex of an anti-microbial ciprofloxacin derivative\u2014Anti-proliferative and anti-microbial activity","volume":"160","author":"Ude","year":"2016","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib45","doi-asserted-by":"crossref","first-page":"L343","DOI":"10.1152\/ajplung.00030.2006","article-title":"Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1\/2, JNK, and NF-\u03baB activation in a cystic fibrosis epithelial cell line","volume":"292","author":"Blau","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pharep.2017.07.007","article-title":"Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells","volume":"70","author":"Beberok","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pharep.2014.07.015","article-title":"Impact of sparfloxacin on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP\u2013An in vitro study","volume":"67","author":"Beberok","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117891_bib48","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/ijo.2012.1653","article-title":"Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC","volume":"41","author":"Kloskowski","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2025.117891_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1560-y","article-title":"Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation","volume":"15","author":"Yadav","year":"2015","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117891_bib50","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3390\/ijms18102194","article-title":"Lomefloxacin induces oxidative stress and apoptosis in COLO829 melanoma cells","volume":"18","author":"Beberok","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-010713-141310","article-title":"Targeting apoptosis pathways for new cancer therapeutics","volume":"65","author":"Bai","year":"2014","journal-title":"Annu. Rev. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117891_bib52","first-page":"1727","article-title":"Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway","volume":"52","author":"Beberok","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026716","article-title":"Caspase functions in cell death and disease","volume":"7","author":"McIlwain","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117891_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118688","article-title":"Targeting apoptotic caspases in cancer","volume":"1867","author":"Boice","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/jcb.21707","article-title":"Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities","volume":"104","author":"Plati","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib57","article-title":"[Retracted] Apoptosis and molecular targeting therapy in cancer","volume":"2014","author":"Hassan","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2025.117891_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106207","article-title":"Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4\u2013d] pyrimidines: synthesis, antitumor evaluation and molecular modeling study","volume":"129","author":"Salem","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117891_bib59","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I\u2212 DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2025.117891_bib60","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1093\/nar\/gkx742","article-title":"Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt (II)-methionine coordination chemistry","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117891_bib61","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/bi00437a018","article-title":"On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex","volume":"28","author":"Hertzberg","year":"1989","journal-title":"Biochemistry"},{"issue":"27","key":"10.1016\/j.ejmech.2025.117891_bib62","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.13005\/bpj\/2396","article-title":"The DNA-topoisomerase inhibitors in cancer therapy","volume":"15","author":"Mastrangelo","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117891_bib64","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1016\/j.bmcl.2014.06.015","article-title":"Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies","volume":"24","author":"Evranos-Aks\u00f6z","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117891_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09553008514552531","article-title":"Cell cycle analysis using flow cytometry","volume":"49","author":"Gray","year":"1986","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.ejmech.2025.117891_bib66","series-title":"Checkpoint Controls and Cancer: Volume 2: Activation and Regulation Protocols","first-page":"301","article-title":"Analysis of cell cycle by flow cytometry","author":"Pozarowski","year":"2004"},{"key":"10.1016\/j.ejmech.2025.117891_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1013560828090","article-title":"Annexin V expression in apoptotic peripheral blood lymphocytes: an electron microscopic evaluation","volume":"7","author":"Cornelissen","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2025.117891_bib68","first-page":"195","article-title":"Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein","volume":"112","author":"Towbin","year":"1979","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117891_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"45","key":"10.1016\/j.ejmech.2025.117891_bib70","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117891_bib71","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.3390\/ijms25168588","article-title":"Correlation between molecular docking and the stabilizing interaction of HOMO-LUMO: spirostans in CHK1 and CHK2, an In Silico cancer approach","volume":"25","author":"Rosales-L\u00f3pez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117891_bib72","series-title":"Protein Preparation Wizard, Epik, Schr\u00f6dinger, Llc, New York, Ny, 2021. Impact","author":"\u00f6dinger Release","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117891_bib73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-1-4939-1465-4_20","article-title":"Molecular docking to flexible targets","author":"S\u00f8rensen","year":"2015","journal-title":"Molecul. Model. Proteins"},{"key":"10.1016\/j.ejmech.2025.117891_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo [3, 4-d] pyrimidine\/1, 2, 4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: design, synthesis, in silico and in vivo studies","author":"Aziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117891_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141504","article-title":"Microwave assisted synthesis, biological assessment and in-silico studies of some new 5, 5\u2032-(phenylmethylene) bisuracil and dihydropyrido [2, 3-d: 6, 5-d'] dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities","author":"Hayallah","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117891_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13568-025-01835-3","article-title":"Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa","volume":"15","author":"Alyahyawy","year":"2025","journal-title":"AMB Express"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:46:11Z","timestamp":1754988371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":76,"alternative-id":["S0223523425006567"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117891","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117891"}}